Results 21 to 30 of about 148,798 (282)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development

open access: yesNaunyn-Schmiedeberg's Archives of Pharmacology, 2019
Cyclic guanosine monophosphate (cGMP) is a unique second messenger molecule formed in different cell types and tissues. cGMP targets a variety of downstream effector molecules and, thus, elicits a very broad variety of cellular effects. Its production is
A. Friebe, P. Sandner, A. Schmidtko
semanticscholar   +1 more source

Regulation of intracellular cyclic GMP concentration by light and calcium in electropermeabilized rod photoreceptors. [PDF]

open access: yes, 1994
This study examines the regulation of cGMP by illumination and by calcium during signal transduction in vertebrate retinal photoreceptor cells. We employed an electropermeabilized rod outer segment (EP-ROS) preparation which permits perfusion of low ...
Coccia, V J, Cote, Rick H.
core   +2 more sources

It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3

open access: yesCommunications Biology, 2023
The occurrence of NO/cGMP signalling in cardiac cells is a matter of debate. Recent measurements with a FRET-based cGMP indicator in isolated cardiac cells revealed NO-induced cGMP signals in cardiac fibroblasts while cardiomyocytes were devoid of these ...
Lukas Menges   +7 more
doaj   +1 more source

Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1989
Nitric oxide, which mediates influences of numerous neurotransmitters and modulators on vascular smooth muscle and leukocytes, can be formed in the brain from arginine by an enzymatic activity that stoichiometrically generates citrulline.
D. Bredt, S. Snyder
semanticscholar   +1 more source

Deciphering cGMP signatures and cGMP-dependent pathways in plant defence [PDF]

open access: yesPlant Signaling & Behavior, 2009
The second messenger, 3′,5′-cyclic monophosphate (cGMP), is a critical component of many different processes in plants while guanylyl cyclases that catalyse the formation of cGMP from GTP have remained somewhat elusive in higher plants. Consequently, two major aims are the discovery of novel GCs and the identification of cGMP mediated processes ...
Meier S.   +5 more
openaire   +4 more sources

Estimating the rate constant of cyclic GMP hydrolysis by activated phosphodiesterase in photoreceptors [PDF]

open access: yes, 2008
The early steps of light response occur in the outer segment of rod and cone photoreceptor. They involve the hydrolysis of cGMP, a soluble cyclic nucleotide, that gates ionic channels located in the outer segment membrane. We shall study here the rate by
Holcman, david, Reingruber, Juergen
core   +2 more sources

β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes

open access: yeseLife, 2020
Cardiomyocyte β3-adrenoceptors (β3-ARs) coupled to soluble guanylyl cyclase (sGC)-dependent production of the second messenger 3’,5’-cyclic guanosine monophosphate (cGMP) have been shown to protect from heart failure.
Sophie Schobesberger   +9 more
doaj   +1 more source

The role of cGMP and PKG-I in spinal nociceptive processing [PDF]

open access: yes, 2005
First paragraph (this article has no abstract) Persistent stimulation of nociceptors results in sensitization of nociceptive sensory neurons, which is associated with hyperalgesia and allodynia.
Geisslinger, Gerd   +5 more
core   +1 more source

In Silico Mapping of Essential Residues in the Catalytic Domain of PDE5 Responsible for Stabilization of Its Commercial Inhibitors

open access: yesScientia Pharmaceutica, 2019
Phosphodiesterase type 5 (PDE5) is an important enzyme associated with the hydrolysis of cyclic guanosine monophosphate (cGMP) to guanosine monophosphate (GMP).
Ivan Pires de Oliveira   +2 more
doaj   +1 more source

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.

open access: yesPLoS ONE, 2022
IntroductionManagement of phenylketonuria (PKU) is mainly achieved through dietary control with limited intake of phenylalanine (Phe) from food, supplemented with low protein (LP) food and a mixture of free synthetic (FS) amino acids (AA) (FSAA).
Kirsten K Ahring   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy